| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 74.931 | 58.173 | 101.191 | 160.346 | 150.938 | 144.208 | 188.349 | 186.633 | 178.415 |
| Total Income - EUR | - | 74.938 | 58.175 | 101.191 | 160.346 | 150.938 | 144.208 | 188.349 | 186.633 | 178.686 |
| Total Expenses - EUR | - | 3.101 | 4.633 | 8.839 | 33.288 | 29.619 | 30.787 | 32.182 | 32.407 | 40.149 |
| Gross Profit/Loss - EUR | - | 71.836 | 53.541 | 92.352 | 127.058 | 121.319 | 113.422 | 156.167 | 154.226 | 138.537 |
| Net Profit/Loss - EUR | - | 69.588 | 51.796 | 89.316 | 125.451 | 119.938 | 112.006 | 154.321 | 152.395 | 133.284 |
| Employees | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Fulgamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 22.148 | 45.594 | 61.186 | 59.212 | 52.516 | 38.703 | 27.953 | 20.148 | 13.101 |
| Current Assets | - | 47.826 | 6.982 | 29.112 | 58.314 | 61.448 | 68.441 | 123.034 | 130.794 | 120.113 |
| Inventories | - | 2.860 | 0 | 0 | 7.891 | 4.113 | 4.022 | 4.034 | 4.022 | 4.044 |
| Receivables | - | 0 | 0 | 0 | 44.364 | 310 | 0 | 117.626 | 115.951 | 97.762 |
| Cash | - | 44.967 | 6.982 | 29.112 | 6.059 | 57.025 | 64.419 | 1.374 | 10.822 | 18.306 |
| Shareholders Funds | - | 69.633 | 51.849 | 89.368 | 125.502 | 119.987 | 112.054 | 154.369 | 152.444 | 133.332 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 341 | 727 | 930 | 997 | 1.876 | 1.931 | 2.595 | 3.574 | 4.052 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Fulgamed Srl